## Abstract Studies are described on the metabolism and the toxicological detection of the amphetamine‐derived designer drug 2,4,5‐trimethoxyamphetamine (TMA‐2) in rat urine using gas chromatographic/mass spectrometric (GC/MS) techniques. The identified metabolites indicated that TMA‐2 was metaboli
New designer drug α-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques
✍ Scribed by Christoph Sauer; Frank T. Peters; Claudia Haas; Markus R. Meyer; Giselher Fritschi; Hans H. Maurer
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 227 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1076-5174
- DOI
- 10.1002/jms.1571
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The aim of the present study was to identify the metabolites of the new designer drug α‐pyrrolidinovalerophenone (PVP) in rat urine using GC/MS techniques. Eleven metabolites of PVP could be identified suggesting the following metabolic steps: hydroxylation of the side chain followed by dehydrogenation to the corresponding ketone; hydroxylation of the 2″‐position of the pyrrolidine ring followed by dehydrogenation to the corresponding lactam or followed by ring opening to the respective aliphatic aldehyde and further oxidation to the respective carboxylic acid; degradation of the pyrrolidine ring to the corresponding primary amine; and hydroxylation of the phenyl ring, most probably in the 4′‐position. The authors' screening procedure for pyrrolidinophenones allowed the detection of PVP metabolites after application of a dose corresponding to a presumed user's dose. In addition, the involvement of nine different human cytochrome P450 (CYP) isoenzymes in the side chain hydroxylation of PVP was investigated and CYP 2B6, 2C19, 2D6, and 3A4 were found to catalyze this reaction. Copyright © 2009 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Studies are described on the metabolism and toxicological detection of the phencyclidine‐derived designer drug __N__‐(1‐phenylcyclohexyl)‐3‐ethoxypropanamine (PCEPA) in rat urine using gas chromatographic/mass spectrometric techniques. The identified metabolites indicated that PCEPA was
## Abstract Studies are described on the metabolism and the toxicological analysis of the phenethylamine‐derived designer drug 4‐iodo‐2,5‐dimethoxy‐β‐phenethylamine (2C‐I) in rat urine using gas chromatographic/mass spectrometric (GC/MS) techniques, and for a particular question, using capillary el
## Abstract The phenethylamine‐derived designer drug 2,5‐dimethoxy‐4‐methyl‐β‐phenethylamine (2C‐D) was found to be metabolized in rats by __O__‐demethylation at position 2 or 5 followed by __N__‐acetylation or by deamination with oxidation to the corresponding acids or reduction to the correspondi
## Abstract Studies are described on the metabolism and toxicological analysis of the piperazine‐derived designer drug 1‐(3,4‐methylenedioxybenzyl)piperazine (MDBP) in rat urine using gas chromatography/mass spectrometry (GC/MS). The identified metabolites indicated that MDBP was metabolized by dem
## Abstract Studies are described on the metabolism and the toxicological detection of the phencyclidine‐derived designer drugs __N__‐(1‐phenylcyclohexyl)‐2‐ethoxyethanamine (PCEEA) and __N__‐(1‐phenylcyclohexyl)‐2‐methoxyethanamine (PCMEA) in rat urine using gas chromatographic/mass spectrometric